person · Reporting owner

VERHOEF CLARENCE R

Disclosed activity across 2 companies

Tapewire entity: 151549
SEC CIK: 0001555927

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
VARIAN MEDICAL SYSTEMS INCVAR · Entity 140252	SVP, Finance, Corp Controller	November 21, 2016	November 22, 2016
Varex Imaging CorpVREX · Entity 5135	SVP & Chief Financial Officer	February 14, 2020	February 19, 2020

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

VARIAN MEDICAL SYSTEMS INC

Report date November 21, 2016 · Filed November 22, 2016

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	5,576	Ending reported balance After 2016-11-21 transaction · row 2 2 source rows · reconciled sequence Row 1 · 2016-11-21 · Exercise / conversion · Acquired 1,347 · Balance 6,050 F1: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. Row 2 · 2016-11-21 · Tax withholding · Disposed 474 · Balance 5,576 F2: Represents shares withheld from vested restricted stock units for the payment of federal, state and payroll taxes due on vesting.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	4,587	Reported balance After 2016-11-21 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2016-11-21 · Exercise / conversion · Disposed 1,347 · Balance 4,587 F1: Each restricted stock unit represents a contingent right to receive one share of VAR common stock. F3: The restricted stock units vest in three equal installments on November 21, 2014, November 21, 2015, and November 21, 2016. Vested shares will be delivered to the reporting person on vest date.

Filing footnotes · ownership attribution and instrument terms

F1: Each restricted stock unit represents a contingent right to receive one share of VAR common stock.

F2: Represents shares withheld from vested restricted stock units for the payment of federal, state and payroll taxes due on vesting.

F3: The restricted stock units vest in three equal installments on November 21, 2014, November 21, 2015, and November 21, 2016. Vested shares will be delivered to the reporting person on vest date.

Varex Imaging Corp

Report date February 14, 2020 · Filed February 19, 2020

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	24,434	Reported balance After 2020-02-14 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2020-02-14 · Exercise / conversion · Acquired 2,413 · Balance 24,434 F1: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F2: Amount of securities beneficially owned at end of reporting period reflect 70 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan.
Common StockSEC Table I · non-derivative	Direct	26,254	Reported balance After 2020-02-14 transaction · row 2 Account or security details depend on footnotes; rows are not merged. 1 source row Row 2 · 2020-02-14 · Exercise / conversion · Acquired 1,820 · Balance 26,254 F1: Each Restricted Stock Unit converts into common stock on a one-for-one basis.
Common StockSEC Table I · non-derivative	Direct	28,403	Reported balance After 2020-02-14 transaction · row 3 Account or security details depend on footnotes; rows are not merged. 1 source row Row 3 · 2020-02-14 · Exercise / conversion · Acquired 2,149 · Balance 28,403 F1: Each Restricted Stock Unit converts into common stock on a one-for-one basis.
Common StockSEC Table I · non-derivative	Direct	26,395	Reported balance After 2020-02-14 transaction · row 4 Account or security details depend on footnotes; rows are not merged. 1 source row Row 4 · 2020-02-14 · Tax withholding · Disposed 2,008 · Balance 26,395 F3: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	2,414	Reported balance After 2020-02-14 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2020-02-14 · Exercise / conversion · Disposed 2,413 · Balance 2,414 F1: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4: These Restricted Stock Units granted on February 16, 2017 vest 25% each year for four years beginning on February 15, 2018. Vested shares will be delivered to the reporting person upon vest date.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	3,640	Reported balance After 2020-02-14 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2020-02-14 · Exercise / conversion · Disposed 1,820 · Balance 3,640 F1: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F5: These Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	6,447	Reported balance After 2020-02-14 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2020-02-14 · Exercise / conversion · Disposed 2,149 · Balance 6,447 F1: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F6: These Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date.

Filing footnotes · ownership attribution and instrument terms

F1: Each Restricted Stock Unit converts into common stock on a one-for-one basis.

F2: Amount of securities beneficially owned at end of reporting period reflect 70 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan.

F3: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein.

F4: These Restricted Stock Units granted on February 16, 2017 vest 25% each year for four years beginning on February 15, 2018. Vested shares will be delivered to the reporting person upon vest date.

F5: These Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date.

F6: These Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
February 14, 2020 Filed Feb 19, 2020 20:37 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionRestricted Stock Units · Derivative	2,149	$0.00	$0.00	Disclosure SEC source: 0001681622-20-000026 · wf-form4_158216260305466.xml · derivative · entry 7 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,447 Underlying: Common Stock · 2,149 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F6 · derivative.exercise_date: These Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date. F6 · derivative.expiration_date: These Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date. Read SEC document
February 14, 2020 Filed Feb 19, 2020 20:37 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionRestricted Stock Units · Derivative	1,820	$0.00	$0.00	Disclosure SEC source: 0001681622-20-000026 · wf-form4_158216260305466.xml · derivative · entry 6 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,640 Underlying: Common Stock · 1,820 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F5 · derivative.exercise_date: These Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.expiration_date: These Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date. Read SEC document
February 14, 2020 Filed Feb 19, 2020 20:37 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionRestricted Stock Units · Derivative	2,413	$0.00	$0.00	Disclosure SEC source: 0001681622-20-000026 · wf-form4_158216260305466.xml · derivative · entry 5 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,414 Underlying: Common Stock · 2,413 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These Restricted Stock Units granted on February 16, 2017 vest 25% each year for four years beginning on February 15, 2018. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: These Restricted Stock Units granted on February 16, 2017 vest 25% each year for four years beginning on February 15, 2018. Vested shares will be delivered to the reporting person upon vest date. Read SEC document
February 14, 2020 Filed Feb 19, 2020 20:37 UTC	Varex Imaging Corp VREX · Entity 5135	Tax withholdingCommon Stock	2,008	$25.89	$51,987.12	Disclosure SEC source: 0001681622-20-000026 · wf-form4_158216260305466.xml · nonDerivative · entry 4 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,395 F3 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document
February 14, 2020 Filed Feb 19, 2020 20:37 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionCommon Stock	2,149	$0.00	$0.00	Disclosure SEC source: 0001681622-20-000026 · wf-form4_158216260305466.xml · nonDerivative · entry 3 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,403 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document
February 14, 2020 Filed Feb 19, 2020 20:37 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionCommon Stock	1,820	$0.00	$0.00	Disclosure SEC source: 0001681622-20-000026 · wf-form4_158216260305466.xml · nonDerivative · entry 2 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,254 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document
February 14, 2020 Filed Feb 19, 2020 20:37 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionCommon Stock	2,413	$0.00	$0.00	Disclosure SEC source: 0001681622-20-000026 · wf-form4_158216260305466.xml · nonDerivative · entry 1 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,434 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F2 · balance_after: Amount of securities beneficially owned at end of reporting period reflect 70 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan. Read SEC document
October 16, 2019 Filed Oct 17, 2019 17:43 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative	21,047	$0.00 Strike: $22.84	$0.00	Disclosure SEC source: 0001681622-19-000074 · wf-form4_157134858767853.xml · derivative · entry 3 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,047 shares Expires 2019-11-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options were granted in connection with the spin-off from Varian Medical Systems, Inc. and were immediately exercisable because they replaced Varian options that had previously vested. Read SEC document
October 16, 2019 Filed Oct 17, 2019 17:43 UTC	Varex Imaging Corp VREX · Entity 5135	SaleCommon Stock	21,047	$28.94	$609,100.18	Disclosure SEC source: 0001681622-19-000074 · wf-form4_157134858767853.xml · nonDerivative · entry 2 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,951 F2 · price: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on May 28, 2019. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.62 to $29.36. The reporting person undertakes to provide Varex Imaging Corporation, any security holder of Varex Imaging Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document
October 16, 2019 Filed Oct 17, 2019 17:43 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionCommon Stock	21,047	$22.84	$480,713.48	Disclosure SEC source: 0001681622-19-000074 · wf-form4_157134858767853.xml · nonDerivative · entry 1 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,998 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 901 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan. Read SEC document
February 15, 2019 Filed Feb 20, 2019 19:59 UTC	Varex Imaging Corp VREX · Entity 5135	GrantNon-Qualified Stock Option (right to buy) · Derivative	26,507	$0.00 Strike: $31.42	$0.00	Disclosure SEC source: 0001681622-19-000039 · wf-form4_155071072904078.xml · derivative · entry 9 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,507 Underlying: Common Stock · 26,507 shares Expires 2026-02-15 F8 · derivative.exercise_date: This Non-Qualified Stock Option is subject to a four-year vesting schedule. 25% of the total number of options vests one year from grant date, and the remaining options vests monthly thereafter on a pro rata basis. Read SEC document
February 15, 2019 Filed Feb 20, 2019 19:59 UTC	Varex Imaging Corp VREX · Entity 5135	GrantRestricted Stock Units · Derivative	8,596	$0.00	$0.00	Disclosure SEC source: 0001681622-19-000039 · wf-form4_155071072904078.xml · derivative · entry 8 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,596 Underlying: Common Stock · 8,596 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F7 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date. F7 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2019 vest 25% each year for four years beginning on February 15, 2020. Vested shares will be delivered to the reporting person upon vest date. Read SEC document
February 15, 2019 Filed Feb 20, 2019 19:59 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionRestricted Stock Units · Derivative	1,820	$0.00	$0.00	Disclosure SEC source: 0001681622-19-000039 · wf-form4_155071072904078.xml · derivative · entry 7 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,460 Underlying: Common Stock · 1,820 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F6 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date. F6 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date. Read SEC document
February 15, 2019 Filed Feb 20, 2019 19:59 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionRestricted Stock Units · Derivative	2,413	$0.00	$0.00	Disclosure SEC source: 0001681622-19-000039 · wf-form4_155071072904078.xml · derivative · entry 6 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,827 Underlying: Common Stock · 2,413 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F5 · derivative.exercise_date: These Restricted Stock Units vest 25% each year for four years with the first vesting date being February 15, 2018. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.expiration_date: These Restricted Stock Units vest 25% each year for four years with the first vesting date being February 15, 2018. Vested shares will be delivered to the reporting person upon vest date. Read SEC document
February 15, 2019 Filed Feb 20, 2019 19:59 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionRestricted Stock Units · Derivative	2,871	$0.00	$0.00	Disclosure SEC source: 0001681622-19-000039 · wf-form4_155071072904078.xml · derivative · entry 5 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,871 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These Restricted Stock Units vest in three equal annual installments with the first vesting date being February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: These Restricted Stock Units vest in three equal annual installments with the first vesting date being February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. Read SEC document
February 15, 2019 Filed Feb 20, 2019 19:59 UTC	Varex Imaging Corp VREX · Entity 5135	Tax withholdingCommon Stock	2,127	$31.42	$66,830.34	Disclosure SEC source: 0001681622-19-000039 · wf-form4_155071072904078.xml · nonDerivative · entry 4 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,050 F3 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document
February 15, 2019 Filed Feb 20, 2019 19:59 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionCommon Stock	1,820	Not disclosed	Not disclosed	Disclosure SEC source: 0001681622-19-000039 · wf-form4_155071072904078.xml · nonDerivative · entry 3 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,177 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document
February 15, 2019 Filed Feb 20, 2019 19:59 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionCommon Stock	2,413	Not disclosed	Not disclosed	Disclosure SEC source: 0001681622-19-000039 · wf-form4_155071072904078.xml · nonDerivative · entry 2 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,357 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document
February 15, 2019 Filed Feb 20, 2019 19:59 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionCommon Stock	2,871	Not disclosed	Not disclosed	Disclosure SEC source: 0001681622-19-000039 · wf-form4_155071072904078.xml · nonDerivative · entry 1 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,944 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F2 · balance_after: Includes 148 shares acquired under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan. Read SEC document
August 17, 2018 Filed Aug 17, 2018 18:15 UTC	Varex Imaging Corp VREX · Entity 5135	PurchaseCommon Stock	3,300	$29.58	$97,614.00	Disclosure SEC source: 0001681622-18-000033 · wf-form4_153454409633926.xml · nonDerivative · entry 1 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,925 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $29.48 to $29.64 per share, inclusive. The reporting person undertakes to provide Varex Imaging Corporation, any security holder of Varex Imaging Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: Includes 671 shares acquired under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan. Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:52 UTC	Varex Imaging Corp VREX · Entity 5135	GrantNon-Qualified Stock Option (right to buy) · Derivative	22,871	$0.00 Strike: $37.10	$0.00	Disclosure SEC source: 0001214659-18-001423 · marketforms-41075.xml · derivative · entry 9 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,871 Underlying: Common Stock · 22,871 shares Expires 2025-02-15 F8 · derivative.exercise_date: This Non-Qualified Stock Option is subject to a four-year vesting schedule. 25% of the total number of options vests one year from grant date, and the remaining options vests monthly thereafter on a pro rata basis. Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:52 UTC	Varex Imaging Corp VREX · Entity 5135	GrantRestricted Stock Units · Derivative	7,280	$0.00	$0.00	Disclosure SEC source: 0001214659-18-001423 · marketforms-41075.xml · derivative · entry 8 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,280 Underlying: Common Stock · 7,280 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F7 · derivative.exercise_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date. F7 · derivative.expiration_date: The Restricted Stock Units granted on February 15, 2018 vest 25% each year for four years beginning on February 15, 2019. Vested shares will be delivered to the reporting person upon vest date. Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:52 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionRestricted Stock Units · Derivative	1,809	$0.00	$0.00	Disclosure SEC source: 0001214659-18-001423 · marketforms-41075.xml · derivative · entry 7 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,809 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F6 · derivative.exercise_date: These Restricted Stock Units vest in two equal annual installments with the first vesting date being February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F6 · derivative.expiration_date: These Restricted Stock Units vest in two equal annual installments with the first vesting date being February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:52 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionRestricted Stock Units · Derivative	2,870	$0.00	$0.00	Disclosure SEC source: 0001214659-18-001423 · marketforms-41075.xml · derivative · entry 6 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,871 Underlying: Common Stock · 2,870 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F5 · derivative.exercise_date: These Restricted Stock Units vest in three equal annual installments with the first vesting date being February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.expiration_date: These Restricted Stock Units vest in three equal annual installments with the first vesting date being February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:52 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionRestricted Stock Units · Derivative	2,413	$0.00	$0.00	Disclosure SEC source: 0001214659-18-001423 · marketforms-41075.xml · derivative · entry 5 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,240 Underlying: Common Stock · 2,413 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These Restricted Stock Units vest 25% each year for four years with the first vesting date being February 15, 2018. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: These Restricted Stock Units vest 25% each year for four years with the first vesting date being February 15, 2018. Vested shares will be delivered to the reporting person upon vest date. Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:52 UTC	Varex Imaging Corp VREX · Entity 5135	Tax withholdingCommon Stock	2,138	$37.10	$79,319.80	Disclosure SEC source: 0001214659-18-001423 · marketforms-41075.xml · nonDerivative · entry 4 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,954 F3 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:52 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionCommon Stock	1,809	Not disclosed	Not disclosed	Disclosure SEC source: 0001214659-18-001423 · marketforms-41075.xml · nonDerivative · entry 3 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,092 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:52 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionCommon Stock	2,870	Not disclosed	Not disclosed	Disclosure SEC source: 0001214659-18-001423 · marketforms-41075.xml · nonDerivative · entry 2 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,283 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document
February 15, 2018 Filed Feb 20, 2018 20:52 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionCommon Stock	2,413	Not disclosed	Not disclosed	Disclosure SEC source: 0001214659-18-001423 · marketforms-41075.xml · nonDerivative · entry 1 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,413 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F2 · balance_after: Includes 652 shares acquired under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan Read SEC document
February 16, 2017 Filed Feb 17, 2017 20:30 UTC	Varex Imaging Corp VREX · Entity 5135	GrantNon-Qualified Stock Option (right to buy) · Derivative	4,206	$0.00 Strike: $31.08	$0.00	Disclosure SEC source: 0001214659-17-001254 · marketforms-37976.xml · derivative · entry 11 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,206 Underlying: Common Stock · 4,206 shares Expires 2024-02-16 F9 · derivative.exercise_date: This Non-Qualified Stock Option is subject to an one-year cliff from February 15, 2017. Read SEC document
February 16, 2017 Filed Feb 17, 2017 20:30 UTC	Varex Imaging Corp VREX · Entity 5135	GrantNon-Qualified Stock Option (right to buy) · Derivative	13,668	$0.00 Strike: $31.08	$0.00	Disclosure SEC source: 0001214659-17-001254 · marketforms-37976.xml · derivative · entry 10 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,668 Underlying: Common Stock · 13,668 shares Expires 2024-02-16 F8 · derivative.exercise_date: This Non-Qualified Stock Option is subject to a two-year cliff from February 15, 2017. Read SEC document
February 16, 2017 Filed Feb 17, 2017 20:30 UTC	Varex Imaging Corp VREX · Entity 5135	GrantNon-Qualified Stock Option (right to buy) · Derivative	102,197	$0.00 Strike: $31.08	$0.00	Disclosure SEC source: 0001214659-17-001254 · marketforms-37976.xml · derivative · entry 9 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,197 Underlying: Common Stock · 102,197 shares Expires 2024-02-16 F7 · derivative.exercise_date: This Non-Qualified Stock Option is subject to a four-year vesting schedule. 25% of the total number of shares vests one year from grant date, and the remaining 75% vests monthly thereafter. Read SEC document
February 16, 2017 Filed Feb 17, 2017 20:30 UTC	Varex Imaging Corp VREX · Entity 5135	GrantRestricted Stock Units · Derivative	9,653	$0.00	$0.00	Disclosure SEC source: 0001214659-17-001254 · marketforms-37976.xml · derivative · entry 8 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,203 Underlying: Common Stock · 9,653 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F6 · derivative.exercise_date: The Restricted Stock Units granted on February 16, 2017 vest 25% each year for four years beginning on February 15, 2018. Vested shares will be delivered to the reporting person upon vest date. F6 · derivative.expiration_date: The Restricted Stock Units granted on February 16, 2017 vest 25% each year for four years beginning on February 15, 2018. Vested shares will be delivered to the reporting person upon vest date. Read SEC document
February 16, 2017 Filed Feb 24, 2017 18:09 UTC Amendment	Varex Imaging Corp VREX · Entity 5135	GrantNon-Qualified Stock Option (right to buy) · Derivative	4,795	$0.00 Strike: $31.08	$0.00	Disclosure SEC source: 0001214659-17-001366 · marketforms-38016.xml · derivative · entry 2 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,795 Underlying: Common Stock · 4,795 shares Expires 2024-02-16 F1 · shares: The original Form 4 filed on February 17, 2017 is amended by this Form 4 amendment to correctly reflect the number of stock options granted. No other changes have been made to the original Form 4. F3 · derivative.exercise_date: This Non-Qualified Stock Option is subject to an one-year cliff from February 15, 2017. F1 · derivative.underlying_shares: The original Form 4 filed on February 17, 2017 is amended by this Form 4 amendment to correctly reflect the number of stock options granted. No other changes have been made to the original Form 4. F1 · balance_after: The original Form 4 filed on February 17, 2017 is amended by this Form 4 amendment to correctly reflect the number of stock options granted. No other changes have been made to the original Form 4. Read SEC document
February 16, 2017 Filed Feb 24, 2017 18:09 UTC Amendment	Varex Imaging Corp VREX · Entity 5135	GrantNon-Qualified Stock Option (right to buy) · Derivative	14,537	$0.00 Strike: $31.08	$0.00	Disclosure SEC source: 0001214659-17-001366 · marketforms-38016.xml · derivative · entry 1 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,537 Underlying: Common Stock · 14,537 shares Expires 2024-02-16 F1 · shares: The original Form 4 filed on February 17, 2017 is amended by this Form 4 amendment to correctly reflect the number of stock options granted. No other changes have been made to the original Form 4. F2 · derivative.exercise_date: This Non-Qualified Stock Option is subject to a two-year cliff from February 15, 2017. F1 · derivative.underlying_shares: The original Form 4 filed on February 17, 2017 is amended by this Form 4 amendment to correctly reflect the number of stock options granted. No other changes have been made to the original Form 4. F1 · balance_after: The original Form 4 filed on February 17, 2017 is amended by this Form 4 amendment to correctly reflect the number of stock options granted. No other changes have been made to the original Form 4. Read SEC document
February 15, 2017 Filed Feb 17, 2017 20:30 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionRestricted Stock Units · Derivative	2,870	$0.00	$0.00	Disclosure SEC source: 0001214659-17-001254 · marketforms-37976.xml · derivative · entry 7 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,741 Underlying: Common Stock · 1,601 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F5 · derivative.exercise_date: These Restricted Stock Units vest in three equal annual installments beginning February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F5 · derivative.expiration_date: These Restricted Stock Units vest in three equal annual installments beginning February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. Read SEC document
February 15, 2017 Filed Feb 17, 2017 20:30 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionRestricted Stock Units · Derivative	1,809	$0.00	$0.00	Disclosure SEC source: 0001214659-17-001254 · marketforms-37976.xml · derivative · entry 6 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,809 Underlying: Common Stock · 1,809 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F4 · derivative.exercise_date: These Restricted Stock Units vest in two equal annual installments beginning February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F4 · derivative.expiration_date: These Restricted Stock Units vest in two equal annual installments beginning February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. Read SEC document
February 15, 2017 Filed Feb 17, 2017 20:30 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionRestricted Stock Units · Derivative	1,601	$0.00	$0.00	Disclosure SEC source: 0001214659-17-001254 · marketforms-37976.xml · derivative · entry 5 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,601 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. F3 · derivative.exercise_date: These Restricted Stock Units vest February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F3 · derivative.expiration_date: These Restricted Stock Units vest February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. Read SEC document
February 15, 2017 Filed Feb 17, 2017 20:30 UTC	Varex Imaging Corp VREX · Entity 5135	Tax withholdingCommon Stock	2,162	$29.93	$64,708.66	Disclosure SEC source: 0001214659-17-001254 · marketforms-37976.xml · nonDerivative · entry 4 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,118 F2 · shares: These shares represent shares withheld for satisfaction of a tax withholding obligation arising as a result of the vesting of the Restricted Stock Units reported herein. Read SEC document
February 15, 2017 Filed Feb 17, 2017 20:30 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionCommon Stock	2,870	Not disclosed	Not disclosed	Disclosure SEC source: 0001214659-17-001254 · marketforms-37976.xml · nonDerivative · entry 3 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,280 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document
February 15, 2017 Filed Feb 17, 2017 20:30 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionCommon Stock	1,809	Not disclosed	Not disclosed	Disclosure SEC source: 0001214659-17-001254 · marketforms-37976.xml · nonDerivative · entry 2 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,410 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document
February 15, 2017 Filed Feb 17, 2017 20:30 UTC	Varex Imaging Corp VREX · Entity 5135	Exercise / conversionCommon Stock	1,601	Not disclosed	Not disclosed	Disclosure SEC source: 0001214659-17-001254 · marketforms-37976.xml · nonDerivative · entry 1 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,601 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit converts into common stock on a one-for-one basis. Read SEC document
January 28, 2017 Filed Jan 31, 2017 21:04 UTC	Varex Imaging Corp VREX · Entity 5135	GrantRestricted Stock Units · Derivative	0	$0.00	$0.00	Disclosure SEC source: 0001214659-17-000585 · marketforms-37684.xml · derivative · entry 7 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires not disclosed F6 · derivative.exercise_price: In connection with the Spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F6 · shares: In connection with the Spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F9 · derivative.exercise_date: These RSUs vest in three equal annual installments beginning on February 12, 2017. Vested shares will be delivered to the reporting person upon vest date. F9 · derivative.expiration_date: These RSUs vest in three equal annual installments beginning on February 12, 2017. Vested shares will be delivered to the reporting person upon vest date. F6 · derivative.underlying_shares: In connection with the Spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F6 · balance_after: In connection with the Spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document
January 28, 2017 Filed Jan 31, 2017 21:04 UTC	Varex Imaging Corp VREX · Entity 5135	GrantRestricted Stock Units · Derivative	0	$0.00	$0.00	Disclosure SEC source: 0001214659-17-000585 · marketforms-37684.xml · derivative · entry 6 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires not disclosed F6 · derivative.exercise_price: In connection with the Spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F6 · shares: In connection with the Spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F8 · derivative.exercise_date: These RSUs vest in two equal annual installments beginning on February 13, 2017. Vested shares will be delivered to the reporting person upon vest date. F8 · derivative.expiration_date: These RSUs vest in two equal annual installments beginning on February 13, 2017. Vested shares will be delivered to the reporting person upon vest date. F6 · derivative.underlying_shares: In connection with the Spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F6 · balance_after: In connection with the Spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document
January 28, 2017 Filed Jan 31, 2017 21:04 UTC	Varex Imaging Corp VREX · Entity 5135	GrantRestricted Stock Units · Derivative	0	$0.00	$0.00	Disclosure SEC source: 0001214659-17-000585 · marketforms-37684.xml · derivative · entry 5 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires not disclosed F6 · derivative.exercise_price: In connection with the Spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F6 · shares: In connection with the Spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F7 · derivative.exercise_date: These RSUs vest February 21, 2017. Vested shares will be delivered to the reporting person upon vest date. F7 · derivative.expiration_date: These RSUs vest February 21, 2017. Vested shares will be delivered to the reporting person upon vest date. F6 · derivative.underlying_shares: In connection with the Spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F6 · balance_after: In connection with the Spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. Once the number of shares of the Issuer's common stock underlying this RSU award has been determined, an amended Form 4 will be filed disclosing such information. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document
January 28, 2017 Filed Jan 31, 2017 21:04 UTC	Varex Imaging Corp VREX · Entity 5135	GrantNon-Qualified Stock Option (right to buy) · Derivative	0	$0.00	$0.00	Disclosure SEC source: 0001214659-17-000585 · marketforms-37684.xml · derivative · entry 4 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires 2023-02-12 F1 · derivative.exercise_price: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F1 · shares: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F5 · derivative.exercise_date: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 12, 2016 and the remaining vests monthly thereafter. F1 · derivative.underlying_shares: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F1 · balance_after: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. Read SEC document
January 28, 2017 Filed Jan 31, 2017 21:04 UTC	Varex Imaging Corp VREX · Entity 5135	GrantNon-Qualified Stock Option (right to buy) · Derivative	0	$0.00	$0.00	Disclosure SEC source: 0001214659-17-000585 · marketforms-37684.xml · derivative · entry 3 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires 2022-02-13 F1 · derivative.exercise_price: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F1 · shares: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F4 · derivative.exercise_date: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 13, 2015 and the remaining vests monthly thereafter. F1 · derivative.underlying_shares: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F1 · balance_after: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. Read SEC document
January 28, 2017 Filed Jan 31, 2017 21:04 UTC	Varex Imaging Corp VREX · Entity 5135	GrantNon-Qualified Stock Option (right to buy) · Derivative	0	$0.00	$0.00	Disclosure SEC source: 0001214659-17-000585 · marketforms-37684.xml · derivative · entry 2 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires 2021-02-21 F1 · derivative.exercise_price: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F1 · shares: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F3 · derivative.exercise_date: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from February 21, 2014 and the remaining vests monthly thereafter. F1 · derivative.underlying_shares: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F1 · balance_after: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. Read SEC document
January 28, 2017 Filed Jan 31, 2017 21:04 UTC	Varex Imaging Corp VREX · Entity 5135	GrantNon-Qualified Stock Option (right to buy) · Derivative	0	$0.00	$0.00	Disclosure SEC source: 0001214659-17-000585 · marketforms-37684.xml · derivative · entry 1 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · Not disclosed shares Expires 2019-11-09 F1 · derivative.exercise_price: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F1 · shares: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F2 · derivative.exercise_date: Option is subject to a three year vesting schedule, 1/3 of the total number of shares vests in one year from November 9, 2012 and the remaining vests monthly thereafter. F1 · derivative.underlying_shares: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. F1 · balance_after: In connection with the Spin-off of the Issuer from Varian Medical Systems Inc. ("Varian") on January 28, 2017 (the "Spin-off"), each outstanding Varian stock option award held by the reporting person was converted into an award of options to purchase shares of the Issuer's common stock. The number of shares underlying the option award, and the exercise price thereof, will be adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian option award. Once the number of shares of the Issuer's common stock underlying this option award, and the exercise price thereof, has been determined, an amended Form 4 will be filed disclosing such information. Read SEC document
January 28, 2017 Filed Feb 9, 2017 21:02 UTC Amendment	Varex Imaging Corp VREX · Entity 5135	GrantRestricted Stock Units · Derivative	8,611	$0.00	$0.00	Disclosure SEC source: 0001214659-17-000914 · marketforms-37818.xml · derivative · entry 7 VERHOEF CLARENCE R · CIK 0001555927 · SVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,830 Underlying: Common Stock · 8,611 shares Expires 2020-02-15 F6 · derivative.exercise_price: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F6 · shares: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F9 · derivative.exercise_date: These RSUs vest in three equal annual installments beginning on February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F9 · derivative.expiration_date: These RSUs vest in three equal annual installments beginning on February 15, 2017. Vested shares will be delivered to the reporting person upon vest date. F6 · derivative.underlying_shares: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. F6 · balance_after: In connection with the spin-off, each outstanding restricted stock unit ("RSU") award held by the reporting person was converted into a RSU award denominated in shares of the Issuer's common stock. The number of shares underlying the RSU award was adjusted (based in part on the simple average of the closing per-share price of Issuer's common stock trading on the Nasdaq Global Select Market during each of the first five full trading sessions following the Spin-off) in a manner intended to preserve the aggregate intrinsic value of the original Varian RSU award. This amendment is being filed to disclose the number of shares of the Issuer's common stock underlying this RSU. Each RSU represents a contingent right to receive one share of the Issuer's underlying common stock. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.